Contract research services company Genome Designs, Inc., US, has announced that it has received seed financing from undisclosed private investors, and started operation. Founded by veterans of Argonne National Lab, NCBI, Integrated Genomics and Ariadne, the company is taking on the challenge of functional annotation of the next-generation sequencing projects for the life science community.
Founded in January 2012, Genome Designs seeks to help life scientists generate value from their sequencing projects, from functional annotation and metabolic modelling to drug development and advancement of bioproduction. The privately owned contract research service company is headed by a team with experience in bioinformatics tool development and metabolic engineering. The team also has prior experience in start-up company operations.
Using proprietary software tools (GD Annotation Suite) and MPW database, the largest collection of metabolic pathways curated since the 1980s, Genome Designs provides genome annotation, pathway analysis and metabolic engineering services, and licenses metabolic designs to pharmaceutical and bioproduction companies.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
